News und Analysen
CI Global Asset Management Launches Global Fixed-Income Mandates
CI Global Asset Management (“CI GAM”) today launched two new global fixed-income mandates, providing Canadian investors with additional options for income and diversification.
The new mandates
EQS-News: Medios AG significantly expands compounding capacity at Berlin site – manufacturing permit granted for new laboratory
EQS-News: Befesa S.A.: Befesa continues to deliver strong results with 9M’22 up 20% yoy and confirms FY guidance towards lower end
EQS-News: HelloFresh SE continues on growth trajectory in strong third quarter
Fuel Tech Releases White Paper Validating Oxygen Transfer Efficiency of Its Dissolved Gas Infusion Technology
Fuel Tech, Inc. (NASDAQ: FTEK), a technology company providing advanced engineering solutions for the optimization of combustion systems, emissions control, and water treatment in utility and
Vistagen to Host Concordia Live Webinar on Mental Health with Leaders from McKinsey Health Institute, WEVO, and In KidZ
Vistagen (Nasdaq: VTGN), a late clinical-stage biopharmaceutical company aiming to transform the treatment landscape for individuals living with anxiety, depression, and other central nervous
Vistagen Announces Results of Voting from 2022 Annual Meeting of Stockholders and Partial Adjournment to October 28, 2022
Vistagen Therapeutics, Inc. (Nasdaq: VTGN) (the Company), a late clinical-stage biopharmaceutical company aiming to transform the treatment landscape for individuals living with anxiety, depression
CI Financial Announces Third Quarter Earnings Conference Call and Webcast
CI Financial Corp. (“CI”) (TSX: CIX; NYSE: CIXX) will release its financial results for the third quarter of fiscal 2022 on Thursday, November 10, 2022.
CI will hold a conference call with
Granite REIT Declares Distribution for October 2022
Granite Real Estate Investment Trust (“Granite”) (TSX: GRT.UN / NYSE: GRP.U) announced today that its board of trustees has declared a distribution of CDN $0.2583 per stapled unit for the month of
CI Financial Reports Total Assets of $338.1 Billion for September 2022
CI Financial Corp. (“CI”) (TSX: CIX, NYSE: CIXX) today reported preliminary total assets of $338.1 billion as at September 30, 2022, consisting of asset management assets of $114.2 billion
CI Global Asset Management Announces October 2022 Distributions for CI ETFs
CI Global Asset Management (“CI GAM”) announces the following regular cash distributions for the month ending October 31, 2022 in respect of the CI ETFs. In all cases, the distribution will be paid
Vistagen Announces the Two Leading Proxy Advisory Firms, Institutional Shareholder Services and Glass Lewis, Recommend Stockholders Vote “FOR” Proposal No. 5 to Provide its Board with the Option to Implement a Future Reverse Stock Split, if Necessary
Vistagen Therapeutics, Inc. (Nasdaq: VTGN) (the Company), a late clinical-stage biopharmaceutical company aiming to transform the treatment landscape for individuals living with anxiety, depression
Vistagen to Participate at Cantor Neurology & Psychiatry Conference
Vistagen (Nasdaq: VTGN), a late clinical-stage biopharmaceutical company aiming to transform the treatment landscape for individuals living with anxiety, depression, and other central nervous
Granite REIT Notice of Conference Call for Third Quarter 2022 Results
Granite Real Estate Investment Trust (“Granite”) (TSX: GRT.UN / NYSE: GRP.U) expects to announce its financial results for the third quarter ended September 30, 2022 after the close of markets on
Mannatech Launches Superfood Greens and Reds at MannaFest 2022
Global health and wellness company Mannatech, Incorporated (NASDAQ: MTEX) just announced the launch of its new product, Superfood Greens and Reds. It was revealed in front of a live and virtual
CI Global Asset Management Expands Fund and ETF Lineup With ESG and Commodities Mandates
CI Global Asset Management (“CI GAM”) today launched three new investment options – two ESG-focused mandates offering both mutual fund and ETF series, and a commodity-focused liquid alternative
Hitachi Metals, Ltd.: Bekanntmachung über die Änderung des Firmennamens
Hitachi Metals, Ltd. (nachfolgend das „Unternehmen“) gibt hiermit bekannt, dass auf der heutigen Sitzung des Board of Directors beschlossen wurde, den Firmennamen des Unternehmens wie weiter unten
Hitachi Metals, Ltd.: Bekanntmachung über die Änderung des Firmennamens
Hitachi Metals, Ltd. (nachfolgend das „Unternehmen“) gibt hiermit bekannt, dass auf der heutigen Sitzung des Board of Directors beschlossen wurde, den Firmennamen des Unternehmens wie weiter unten
Hitachi Metals, Ltd.: Bekanntmachung über die Änderung des Firmennamens
Hitachi Metals, Ltd. (nachfolgend das „Unternehmen“) gibt hiermit bekannt, dass auf der heutigen Sitzung des Board of Directors beschlossen wurde, den Firmennamen des Unternehmens wie weiter unten
Hitachi Metals, Ltd.: Bekanntmachung über die Änderung des Firmennamens
Hitachi Metals, Ltd. (nachfolgend das „Unternehmen“) gibt hiermit bekannt, dass auf der heutigen Sitzung des Board of Directors beschlossen wurde, den Firmennamen des Unternehmens wie weiter unten
Hitachi Metals, Ltd.: Notice Concerning Change of Trade Name
Hitachi Metals, Ltd. (hereinafter, the “Company”) hereby announces that it has been resolved at today’s board of directors’ meeting that the Company’s trade name will be changed as follows.
The
Hitachi Metals, Ltd.: Notice Concerning Change of Trade Name
Hitachi Metals, Ltd. (hereinafter, the “Company”) hereby announces that it has been resolved at today’s board of directors’ meeting that the Company’s trade name will be changed as follows.
The
Hitachi Metals, Ltd.: Notice Concerning Change of Trade Name
Hitachi Metals, Ltd. (hereinafter, the “Company”) hereby announces that it has been resolved at today’s board of directors’ meeting that the Company’s trade name will be changed as follows.
The
Hitachi Metals, Ltd.: Notice Concerning Change of Trade Name
Hitachi Metals, Ltd. (hereinafter, the “Company”) hereby announces that it has been resolved at today’s board of directors’ meeting that the Company’s trade name will be changed as follows.
The
Vistagen CEO Shawn Singh to Join Executive Roundtable Discussing Mental Health at Concordia Annual Summit
Vistagen (Nasdaq: VTGN), a late clinical-stage biopharmaceutical company aiming to transform the treatment landscape for individuals living with anxiety, depression, and other central nervous